While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

While experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing ...

Poor sleep was correlated with conspiracy theory beliefs. (Journal of Health Psychology) Gender-affirming hormone therapy was ...

They also show that models learned from nonsynonymous mutations and from out-of-frame sequences are different, prompting new questions about germinal center function. Strengths of the study include an ...

High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical ...

The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.

Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

The device, dubbed NPM-115, is a miniature sub-dermal implant that delivers exenatide, a glucagon-like peptide-1 receptor ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a ...